Medallia, Inc.

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SAP has a market cap of 335.9B. Regarding current trading prices, MDLA is priced at $33.99, while SAP trades at $288.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SAP's P/E ratio is 50.52. In terms of profitability, MDLA's ROE is -0.33%, compared to SAP's ROE of +0.15%. Regarding short-term risk, MDLA is less volatile compared to SAP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check SAP's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CRM has a market cap of 257.3B. Regarding current trading prices, MDLA is priced at $33.99, while CRM trades at $269.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CRM's P/E ratio is 42.12. In terms of profitability, MDLA's ROE is -0.33%, compared to CRM's ROE of +0.10%. Regarding short-term risk, MDLA is less volatile compared to CRM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CRM's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, INTU has a market cap of 219.2B. Regarding current trading prices, MDLA is priced at $33.99, while INTU trades at $785.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas INTU's P/E ratio is 64.11. In terms of profitability, MDLA's ROE is -0.33%, compared to INTU's ROE of +0.19%. Regarding short-term risk, MDLA is less volatile compared to INTU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check INTU's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, NOW has a market cap of 200.6B. Regarding current trading prices, MDLA is priced at $33.99, while NOW trades at $968.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas NOW's P/E ratio is 121.50. In terms of profitability, MDLA's ROE is -0.33%, compared to NOW's ROE of +0.17%. Regarding short-term risk, MDLA is less volatile compared to NOW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check NOW's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, UBER has a market cap of 191B. Regarding current trading prices, MDLA is priced at $33.99, while UBER trades at $91.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas UBER's P/E ratio is 16.00. In terms of profitability, MDLA's ROE is -0.33%, compared to UBER's ROE of +0.70%. Regarding short-term risk, MDLA is less volatile compared to UBER. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check UBER's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SHOP has a market cap of 161.4B. Regarding current trading prices, MDLA is priced at $33.99, while SHOP trades at $124.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SHOP's P/E ratio is 101.16. In terms of profitability, MDLA's ROE is -0.33%, compared to SHOP's ROE of +0.15%. Regarding short-term risk, MDLA is less volatile compared to SHOP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check SHOP's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, APP has a market cap of 123.3B. Regarding current trading prices, MDLA is priced at $33.99, while APP trades at $364.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas APP's P/E ratio is 65.76. In terms of profitability, MDLA's ROE is -0.33%, compared to APP's ROE of +2.25%. Regarding short-term risk, MDLA is less volatile compared to APP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check APP's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, STRK has a market cap of 119.5B. Regarding current trading prices, MDLA is priced at $33.99, while STRK trades at $107.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas STRK's P/E ratio is N/A. In terms of profitability, MDLA's ROE is -0.33%, compared to STRK's ROE of -0.37%. Regarding short-term risk, MDLA is less volatile compared to STRK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check STRK's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, MSTR has a market cap of 115.1B. Regarding current trading prices, MDLA is priced at $33.99, while MSTR trades at $405.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas MSTR's P/E ratio is -18.25. In terms of profitability, MDLA's ROE is -0.33%, compared to MSTR's ROE of -0.37%. Regarding short-term risk, MDLA is less volatile compared to MSTR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check MSTR's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CDNS has a market cap of 90.7B. Regarding current trading prices, MDLA is priced at $33.99, while CDNS trades at $332.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CDNS's P/E ratio is 84.10. In terms of profitability, MDLA's ROE is -0.33%, compared to CDNS's ROE of +0.22%. Regarding short-term risk, MDLA is less volatile compared to CDNS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CDNS's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SNOW has a market cap of 73.2B. Regarding current trading prices, MDLA is priced at $33.99, while SNOW trades at $219.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SNOW's P/E ratio is -52.39. In terms of profitability, MDLA's ROE is -0.33%, compared to SNOW's ROE of -0.45%. Regarding short-term risk, MDLA is less volatile compared to SNOW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check SNOW's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ADSK has a market cap of 64.9B. Regarding current trading prices, MDLA is priced at $33.99, while ADSK trades at $303.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ADSK's P/E ratio is 64.94. In terms of profitability, MDLA's ROE is -0.33%, compared to ADSK's ROE of +0.46%. Regarding short-term risk, MDLA is less volatile compared to ADSK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ADSK's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, WDAY has a market cap of 64.5B. Regarding current trading prices, MDLA is priced at $33.99, while WDAY trades at $241.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas WDAY's P/E ratio is 133.56. In terms of profitability, MDLA's ROE is -0.33%, compared to WDAY's ROE of +0.06%. Regarding short-term risk, MDLA is less volatile compared to WDAY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check WDAY's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, TEAM has a market cap of 53.4B. Regarding current trading prices, MDLA is priced at $33.99, while TEAM trades at $203.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas TEAM's P/E ratio is -122.29. In terms of profitability, MDLA's ROE is -0.33%, compared to TEAM's ROE of -0.11%. Regarding short-term risk, MDLA is less volatile compared to TEAM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check TEAM's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DDOG has a market cap of 51.7B. Regarding current trading prices, MDLA is priced at $33.99, while DDOG trades at $149.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DDOG's P/E ratio is 318.81. In terms of profitability, MDLA's ROE is -0.33%, compared to DDOG's ROE of +0.06%. Regarding short-term risk, MDLA is less volatile compared to DDOG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DDOG's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, TTD has a market cap of 42.2B. Regarding current trading prices, MDLA is priced at $33.99, while TTD trades at $86.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas TTD's P/E ratio is 105.05. In terms of profitability, MDLA's ROE is -0.33%, compared to TTD's ROE of +0.15%. Regarding short-term risk, MDLA is less volatile compared to TTD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check TTD's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, FICO has a market cap of 37.3B. Regarding current trading prices, MDLA is priced at $33.99, while FICO trades at $1,532.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas FICO's P/E ratio is 65.90. In terms of profitability, MDLA's ROE is -0.33%, compared to FICO's ROE of -0.57%. Regarding short-term risk, MDLA is less volatile compared to FICO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check FICO's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ANSS has a market cap of 32.9B. Regarding current trading prices, MDLA is priced at $33.99, while ANSS trades at $374.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ANSS's P/E ratio is 55.70. In terms of profitability, MDLA's ROE is -0.33%, compared to ANSS's ROE of +0.10%. Regarding short-term risk, MDLA is more volatile compared to ANSS. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check ANSS's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, HUBS has a market cap of 29.5B. Regarding current trading prices, MDLA is priced at $33.99, while HUBS trades at $559.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas HUBS's P/E ratio is -1271.70. In terms of profitability, MDLA's ROE is -0.33%, compared to HUBS's ROE of -0.01%. Regarding short-term risk, MDLA is less volatile compared to HUBS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check HUBS's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, STRF has a market cap of 26.9B. Regarding current trading prices, MDLA is priced at $33.99, while STRF trades at $110.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas STRF's P/E ratio is N/A. In terms of profitability, MDLA's ROE is -0.33%, compared to STRF's ROE of -0.37%. Regarding short-term risk, MDLA is less volatile compared to STRF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check STRF's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PTC has a market cap of 24.5B. Regarding current trading prices, MDLA is priced at $33.99, while PTC trades at $204.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PTC's P/E ratio is 56.20. In terms of profitability, MDLA's ROE is -0.33%, compared to PTC's ROE of +0.14%. Regarding short-term risk, MDLA is less volatile compared to PTC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PTC's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, TYL has a market cap of 24B. Regarding current trading prices, MDLA is priced at $33.99, while TYL trades at $556.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas TYL's P/E ratio is 84.16. In terms of profitability, MDLA's ROE is -0.33%, compared to TYL's ROE of +0.09%. Regarding short-term risk, MDLA is less volatile compared to TYL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check TYL's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ZM has a market cap of 22.6B. Regarding current trading prices, MDLA is priced at $33.99, while ZM trades at $74.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ZM's P/E ratio is 22.47. In terms of profitability, MDLA's ROE is -0.33%, compared to ZM's ROE of +0.12%. Regarding short-term risk, MDLA is less volatile compared to ZM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ZM's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, GRAB has a market cap of 21.2B. Regarding current trading prices, MDLA is priced at $33.99, while GRAB trades at $5.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas GRAB's P/E ratio is 536.00. In terms of profitability, MDLA's ROE is -0.33%, compared to GRAB's ROE of +0.00%. Regarding short-term risk, MDLA is less volatile compared to GRAB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check GRAB's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SSNC has a market cap of 21B. Regarding current trading prices, MDLA is priced at $33.99, while SSNC trades at $85.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SSNC's P/E ratio is 26.87. In terms of profitability, MDLA's ROE is -0.33%, compared to SSNC's ROE of +0.12%. Regarding short-term risk, MDLA is less volatile compared to SSNC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check SSNC's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, GWRE has a market cap of 18.8B. Regarding current trading prices, MDLA is priced at $33.99, while GWRE trades at $223.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas GWRE's P/E ratio is 519.49. In terms of profitability, MDLA's ROE is -0.33%, compared to GWRE's ROE of +0.03%. Regarding short-term risk, MDLA is less volatile compared to GWRE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check GWRE's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BSY has a market cap of 17.1B. Regarding current trading prices, MDLA is priced at $33.99, while BSY trades at $58.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BSY's P/E ratio is 75.12. In terms of profitability, MDLA's ROE is -0.33%, compared to BSY's ROE of +0.25%. Regarding short-term risk, MDLA is less volatile compared to BSY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BSY's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, AZPN has a market cap of 16.7B. Regarding current trading prices, MDLA is priced at $33.99, while AZPN trades at $264.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas AZPN's P/E ratio is 2403.00. In terms of profitability, MDLA's ROE is -0.33%, compared to AZPN's ROE of +0.00%. Regarding short-term risk, MDLA is less volatile compared to AZPN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check AZPN's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DUOL has a market cap of 16.6B. Regarding current trading prices, MDLA is priced at $33.99, while DUOL trades at $364.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DUOL's P/E ratio is 180.24. In terms of profitability, MDLA's ROE is -0.33%, compared to DUOL's ROE of +0.12%. Regarding short-term risk, MDLA is less volatile compared to DUOL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DUOL's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DT has a market cap of 16.3B. Regarding current trading prices, MDLA is priced at $33.99, while DT trades at $54.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DT's P/E ratio is 34.08. In terms of profitability, MDLA's ROE is -0.33%, compared to DT's ROE of +0.21%. Regarding short-term risk, MDLA is less volatile compared to DT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DOCU has a market cap of 16.1B. Regarding current trading prices, MDLA is priced at $33.99, while DOCU trades at $79.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DOCU's P/E ratio is 15.18. In terms of profitability, MDLA's ROE is -0.33%, compared to DOCU's ROE of +0.56%. Regarding short-term risk, MDLA is less volatile compared to DOCU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DOCU's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, QXO has a market cap of 14.9B. Regarding current trading prices, MDLA is priced at $33.99, while QXO trades at $22.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas QXO's P/E ratio is -63.40. In terms of profitability, MDLA's ROE is -0.33%, compared to QXO's ROE of +0.01%. Regarding short-term risk, MDLA is less volatile compared to QXO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check QXO's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, MNDY has a market cap of 14.8B. Regarding current trading prices, MDLA is priced at $33.99, while MNDY trades at $292.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas MNDY's P/E ratio is 295.19. In terms of profitability, MDLA's ROE is -0.33%, compared to MNDY's ROE of +0.05%. Regarding short-term risk, MDLA is less volatile compared to MNDY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check MNDY's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PAYC has a market cap of 13.8B. Regarding current trading prices, MDLA is priced at $33.99, while PAYC trades at $238.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PAYC's P/E ratio is 34.03. In terms of profitability, MDLA's ROE is -0.33%, compared to PAYC's ROE of +0.25%. Regarding short-term risk, MDLA is less volatile compared to PAYC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PAYC's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, U has a market cap of 13.6B. Regarding current trading prices, MDLA is priced at $33.99, while U trades at $32.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas U's P/E ratio is -29.25. In terms of profitability, MDLA's ROE is -0.33%, compared to U's ROE of -0.14%. Regarding short-term risk, MDLA is less volatile compared to U. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check U's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, MANH has a market cap of 13.2B. Regarding current trading prices, MDLA is priced at $33.99, while MANH trades at $217.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas MANH's P/E ratio is 60.99. In terms of profitability, MDLA's ROE is -0.33%, compared to MANH's ROE of +0.80%. Regarding short-term risk, MDLA is less volatile compared to MANH. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check MANH's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BKI has a market cap of 11.9B. Regarding current trading prices, MDLA is priced at $33.99, while BKI trades at $75.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BKI's P/E ratio is 47.96. In terms of profitability, MDLA's ROE is -0.33%, compared to BKI's ROE of +0.06%. Regarding short-term risk, MDLA is less volatile compared to BKI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BKI's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PCOR has a market cap of 11.3B. Regarding current trading prices, MDLA is priced at $33.99, while PCOR trades at $75.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PCOR's P/E ratio is -87.94. In terms of profitability, MDLA's ROE is -0.33%, compared to PCOR's ROE of -0.10%. Regarding short-term risk, MDLA is less volatile compared to PCOR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PCOR's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, XM has a market cap of 11B. Regarding current trading prices, MDLA is priced at $33.99, while XM trades at $18.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas XM's P/E ratio is -10.43. In terms of profitability, MDLA's ROE is -0.33%, compared to XM's ROE of -0.52%. Regarding short-term risk, MDLA is more volatile compared to XM. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check XM's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CDAY has a market cap of 10.9B. Regarding current trading prices, MDLA is priced at $33.99, while CDAY trades at $69.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CDAY's P/E ratio is 2317.33. In terms of profitability, MDLA's ROE is -0.33%, compared to CDAY's ROE of +0.01%. Regarding short-term risk, MDLA is less volatile compared to CDAY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CDAY's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, TTAN has a market cap of 10.6B. Regarding current trading prices, MDLA is priced at $33.99, while TTAN trades at $116.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas TTAN's P/E ratio is -31.44. In terms of profitability, MDLA's ROE is -0.33%, compared to TTAN's ROE of -0.18%. Regarding short-term risk, MDLA is less volatile compared to TTAN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check TTAN's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PCTY has a market cap of 10.4B. Regarding current trading prices, MDLA is priced at $33.99, while PCTY trades at $187.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PCTY's P/E ratio is 46.85. In terms of profitability, MDLA's ROE is -0.33%, compared to PCTY's ROE of +0.20%. Regarding short-term risk, MDLA is less volatile compared to PCTY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PCTY's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, NICE has a market cap of 10.3B. Regarding current trading prices, MDLA is priced at $33.99, while NICE trades at $162.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas NICE's P/E ratio is 22.62. In terms of profitability, MDLA's ROE is -0.33%, compared to NICE's ROE of +0.13%. Regarding short-term risk, MDLA is less volatile compared to NICE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check NICE's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PEGA has a market cap of 10.1B. Regarding current trading prices, MDLA is priced at $33.99, while PEGA trades at $58.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PEGA's P/E ratio is 48.62. In terms of profitability, MDLA's ROE is -0.33%, compared to PEGA's ROE of +0.38%. Regarding short-term risk, MDLA is less volatile compared to PEGA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PEGA's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DAY has a market cap of 9.6B. Regarding current trading prices, MDLA is priced at $33.99, while DAY trades at $60.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DAY's P/E ratio is 375.03. In terms of profitability, MDLA's ROE is -0.33%, compared to DAY's ROE of +0.01%. Regarding short-term risk, MDLA is less volatile compared to DAY. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DAY's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, APPF has a market cap of 9.5B. Regarding current trading prices, MDLA is priced at $33.99, while APPF trades at $264.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas APPF's P/E ratio is 49.35. In terms of profitability, MDLA's ROE is -0.33%, compared to APPF's ROE of +0.45%. Regarding short-term risk, MDLA is less volatile compared to APPF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check APPF's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ESTC has a market cap of 9.5B. Regarding current trading prices, MDLA is priced at $33.99, while ESTC trades at $89.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ESTC's P/E ratio is -86.44. In terms of profitability, MDLA's ROE is -0.33%, compared to ESTC's ROE of -0.13%. Regarding short-term risk, MDLA is less volatile compared to ESTC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ESTC's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DSGX has a market cap of 9.2B. Regarding current trading prices, MDLA is priced at $33.99, while DSGX trades at $107.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DSGX's P/E ratio is 65.25. In terms of profitability, MDLA's ROE is -0.33%, compared to DSGX's ROE of +0.11%. Regarding short-term risk, MDLA is less volatile compared to DSGX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DSGX's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SRAD has a market cap of 8.9B. Regarding current trading prices, MDLA is priced at $33.99, while SRAD trades at $28.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SRAD's P/E ratio is 142.55. In terms of profitability, MDLA's ROE is -0.33%, compared to SRAD's ROE of +0.06%. Regarding short-term risk, MDLA is less volatile compared to SRAD. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check SRAD's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, NATI has a market cap of 8B. Regarding current trading prices, MDLA is priced at $33.99, while NATI trades at $59.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas NATI's P/E ratio is 44.44. In terms of profitability, MDLA's ROE is -0.33%, compared to NATI's ROE of +0.12%. Regarding short-term risk, MDLA is more volatile compared to NATI. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check NATI's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, OTEX has a market cap of 8B. Regarding current trading prices, MDLA is priced at $33.99, while OTEX trades at $30.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas OTEX's P/E ratio is 12.58. In terms of profitability, MDLA's ROE is -0.33%, compared to OTEX's ROE of +0.16%. Regarding short-term risk, MDLA is less volatile compared to OTEX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check OTEX's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, GTLB has a market cap of 7.9B. Regarding current trading prices, MDLA is priced at $33.99, while GTLB trades at $47.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas GTLB's P/E ratio is 532.11. In terms of profitability, MDLA's ROE is -0.33%, compared to GTLB's ROE of +0.02%. Regarding short-term risk, MDLA is less volatile compared to GTLB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check GTLB's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SMAR has a market cap of 7.9B. Regarding current trading prices, MDLA is priced at $33.99, while SMAR trades at $56.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SMAR's P/E ratio is -806.71. In terms of profitability, MDLA's ROE is -0.33%, compared to SMAR's ROE of -0.01%. Regarding short-term risk, MDLA is more volatile compared to SMAR. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check SMAR's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BULL has a market cap of 7.8B. Regarding current trading prices, MDLA is priced at $33.99, while BULL trades at $16.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BULL's P/E ratio is 12.94. In terms of profitability, MDLA's ROE is -0.33%, compared to BULL's ROE of -0.00%. Regarding short-term risk, MDLA is less volatile compared to BULL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BULL's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CVLT has a market cap of 7.3B. Regarding current trading prices, MDLA is priced at $33.99, while CVLT trades at $164.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CVLT's P/E ratio is 97.25. In terms of profitability, MDLA's ROE is -0.33%, compared to CVLT's ROE of +0.26%. Regarding short-term risk, MDLA is less volatile compared to CVLT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CVLT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, COUP has a market cap of 6.1B. Regarding current trading prices, MDLA is priced at $33.99, while COUP trades at $80.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas COUP's P/E ratio is -17.99. In terms of profitability, MDLA's ROE is -0.33%, compared to COUP's ROE of +0.00%. Regarding short-term risk, MDLA is more volatile compared to COUP. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check COUP's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CWAN has a market cap of 6B. Regarding current trading prices, MDLA is priced at $33.99, while CWAN trades at $21.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CWAN's P/E ratio is 12.54. In terms of profitability, MDLA's ROE is -0.33%, compared to CWAN's ROE of +0.59%. Regarding short-term risk, MDLA is less volatile compared to CWAN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CWAN's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, LYFT has a market cap of 5.9B. Regarding current trading prices, MDLA is priced at $33.99, while LYFT trades at $14.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas LYFT's P/E ratio is 95.30. In terms of profitability, MDLA's ROE is -0.33%, compared to LYFT's ROE of +0.08%. Regarding short-term risk, MDLA is less volatile compared to LYFT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check LYFT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, LIF has a market cap of 5.9B. Regarding current trading prices, MDLA is priced at $33.99, while LIF trades at $76.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas LIF's P/E ratio is 590.65. In terms of profitability, MDLA's ROE is -0.33%, compared to LIF's ROE of +0.03%. Regarding short-term risk, MDLA is less volatile compared to LIF. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check LIF's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, IDCC has a market cap of 5.8B. Regarding current trading prices, MDLA is priced at $33.99, while IDCC trades at $224.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas IDCC's P/E ratio is 17.76. In terms of profitability, MDLA's ROE is -0.33%, compared to IDCC's ROE of +0.49%. Regarding short-term risk, MDLA is less volatile compared to IDCC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check IDCC's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, QTWO has a market cap of 5.6B. Regarding current trading prices, MDLA is priced at $33.99, while QTWO trades at $89.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas QTWO's P/E ratio is -262.26. In terms of profitability, MDLA's ROE is -0.33%, compared to QTWO's ROE of -0.04%. Regarding short-term risk, MDLA is less volatile compared to QTWO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check QTWO's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, VERX has a market cap of 5.4B. Regarding current trading prices, MDLA is priced at $33.99, while VERX trades at $34.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas VERX's P/E ratio is -117.97. In terms of profitability, MDLA's ROE is -0.33%, compared to VERX's ROE of -0.20%. Regarding short-term risk, MDLA is less volatile compared to VERX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check VERX's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, RIOT has a market cap of 5.2B. Regarding current trading prices, MDLA is priced at $33.99, while RIOT trades at $14.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas RIOT's P/E ratio is -10.61. In terms of profitability, MDLA's ROE is -0.33%, compared to RIOT's ROE of -0.14%. Regarding short-term risk, MDLA is less volatile compared to RIOT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check RIOT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, FROG has a market cap of 4.8B. Regarding current trading prices, MDLA is priced at $33.99, while FROG trades at $41.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas FROG's P/E ratio is -58.51. In terms of profitability, MDLA's ROE is -0.33%, compared to FROG's ROE of -0.10%. Regarding short-term risk, MDLA is less volatile compared to FROG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check FROG's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BILL has a market cap of 4.7B. Regarding current trading prices, MDLA is priced at $33.99, while BILL trades at $45.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BILL's P/E ratio is -2296.00. In terms of profitability, MDLA's ROE is -0.33%, compared to BILL's ROE of +0.01%. Regarding short-term risk, MDLA is less volatile compared to BILL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BILL's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, SOUN has a market cap of 4.7B. Regarding current trading prices, MDLA is priced at $33.99, while SOUN trades at $11.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas SOUN's P/E ratio is -19.20. In terms of profitability, MDLA's ROE is -0.33%, compared to SOUN's ROE of -0.69%. Regarding short-term risk, MDLA is less volatile compared to SOUN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check SOUN's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CVT has a market cap of 4.2B. Regarding current trading prices, MDLA is priced at $33.99, while CVT trades at $8.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CVT's P/E ratio is -40.57. In terms of profitability, MDLA's ROE is -0.33%, compared to CVT's ROE of -0.06%. Regarding short-term risk, MDLA is more volatile compared to CVT. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check CVT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, FRSH has a market cap of 4.2B. Regarding current trading prices, MDLA is priced at $33.99, while FRSH trades at $14.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas FRSH's P/E ratio is -59.12. In terms of profitability, MDLA's ROE is -0.33%, compared to FRSH's ROE of -0.07%. Regarding short-term risk, MDLA is less volatile compared to FRSH. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check FRSH's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, RUMBW has a market cap of 4.1B. Regarding current trading prices, MDLA is priced at $33.99, while RUMBW trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas RUMBW's P/E ratio is N/A. In terms of profitability, MDLA's ROE is -0.33%, compared to RUMBW's ROE of -1.87%. Regarding short-term risk, MDLA is less volatile compared to RUMBW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check RUMBW's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, RUM has a market cap of 4.1B. Regarding current trading prices, MDLA is priced at $33.99, while RUM trades at $9.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas RUM's P/E ratio is -6.49. In terms of profitability, MDLA's ROE is -0.33%, compared to RUM's ROE of -1.87%. Regarding short-term risk, MDLA is less volatile compared to RUM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check RUM's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PYCR has a market cap of 4.1B. Regarding current trading prices, MDLA is priced at $33.99, while PYCR trades at $22.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PYCR's P/E ratio is -187.42. In terms of profitability, MDLA's ROE is -0.33%, compared to PYCR's ROE of -0.02%. Regarding short-term risk, MDLA is more volatile compared to PYCR. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check PYCR's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ETWO-WT has a market cap of 3.9B. Regarding current trading prices, MDLA is priced at $33.99, while ETWO-WT trades at $0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ETWO-WT's P/E ratio is N/A. In terms of profitability, MDLA's ROE is -0.33%, compared to ETWO-WT's ROE of -0.60%. Regarding short-term risk, MDLA is less volatile compared to ETWO-WT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ETWO-WT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PWSC has a market cap of 3.8B. Regarding current trading prices, MDLA is priced at $33.99, while PWSC trades at $22.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PWSC's P/E ratio is -67.09. In terms of profitability, MDLA's ROE is -0.33%, compared to PWSC's ROE of -0.04%. Regarding short-term risk, MDLA is less volatile compared to PWSC. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PWSC's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, WK has a market cap of 3.8B. Regarding current trading prices, MDLA is priced at $33.99, while WK trades at $67.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas WK's P/E ratio is -58.64. In terms of profitability, MDLA's ROE is -0.33%, compared to WK's ROE of +1.05%. Regarding short-term risk, MDLA is less volatile compared to WK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check WK's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ZI has a market cap of 3.8B. Regarding current trading prices, MDLA is priced at $33.99, while ZI trades at $10.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ZI's P/E ratio is 85.92. In terms of profitability, MDLA's ROE is -0.33%, compared to ZI's ROE of +0.02%. Regarding short-term risk, MDLA is less volatile compared to ZI. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ZI's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, COMP has a market cap of 3.8B. Regarding current trading prices, MDLA is priced at $33.99, while COMP trades at $7.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas COMP's P/E ratio is -55.58. In terms of profitability, MDLA's ROE is -0.33%, compared to COMP's ROE of -0.15%. Regarding short-term risk, MDLA is less volatile compared to COMP. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check COMP's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ZETA has a market cap of 3.8B. Regarding current trading prices, MDLA is priced at $33.99, while ZETA trades at $16.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ZETA's P/E ratio is -64.18. In terms of profitability, MDLA's ROE is -0.33%, compared to ZETA's ROE of -0.10%. Regarding short-term risk, MDLA is less volatile compared to ZETA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ZETA's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CALX has a market cap of 3.6B. Regarding current trading prices, MDLA is priced at $33.99, while CALX trades at $55.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CALX's P/E ratio is -134.85. In terms of profitability, MDLA's ROE is -0.33%, compared to CALX's ROE of -0.03%. Regarding short-term risk, MDLA is less volatile compared to CALX. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CALX's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, GRND has a market cap of 3.6B. Regarding current trading prices, MDLA is priced at $33.99, while GRND trades at $18.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas GRND's P/E ratio is -30.47. In terms of profitability, MDLA's ROE is -0.33%, compared to GRND's ROE of -2.84%. Regarding short-term risk, MDLA is less volatile compared to GRND. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check GRND's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, NCNO has a market cap of 3.6B. Regarding current trading prices, MDLA is priced at $33.99, while NCNO trades at $30.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas NCNO's P/E ratio is -123.24. In terms of profitability, MDLA's ROE is -0.33%, compared to NCNO's ROE of -0.03%. Regarding short-term risk, MDLA is less volatile compared to NCNO. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check NCNO's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, AYX has a market cap of 3.5B. Regarding current trading prices, MDLA is priced at $33.99, while AYX trades at $48.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas AYX's P/E ratio is -19.15. In terms of profitability, MDLA's ROE is -0.33%, compared to AYX's ROE of -0.98%. Regarding short-term risk, MDLA is more volatile compared to AYX. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check AYX's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ASAN has a market cap of 3.5B. Regarding current trading prices, MDLA is priced at $33.99, while ASAN trades at $14.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ASAN's P/E ratio is -14.90. In terms of profitability, MDLA's ROE is -0.33%, compared to ASAN's ROE of -0.93%. Regarding short-term risk, MDLA is less volatile compared to ASAN. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ASAN's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ENV has a market cap of 3.5B. Regarding current trading prices, MDLA is priced at $33.99, while ENV trades at $63.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ENV's P/E ratio is -13.21. In terms of profitability, MDLA's ROE is -0.33%, compared to ENV's ROE of -0.48%. Regarding short-term risk, MDLA is more volatile compared to ENV. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check ENV's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BL has a market cap of 3.5B. Regarding current trading prices, MDLA is priced at $33.99, while BL trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BL's P/E ratio is 40.58. In terms of profitability, MDLA's ROE is -0.33%, compared to BL's ROE of +0.40%. Regarding short-term risk, MDLA is less volatile compared to BL. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BL's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, INST has a market cap of 3.5B. Regarding current trading prices, MDLA is priced at $33.99, while INST trades at $23.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas INST's P/E ratio is -63.78. In terms of profitability, MDLA's ROE is -0.33%, compared to INST's ROE of -0.07%. Regarding short-term risk, MDLA is more volatile compared to INST. This indicates potentially higher risk in terms of short-term price fluctuations for MDLA.Check INST's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, INTA has a market cap of 3.4B. Regarding current trading prices, MDLA is priced at $33.99, while INTA trades at $41.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas INTA's P/E ratio is -173.50. In terms of profitability, MDLA's ROE is -0.33%, compared to INTA's ROE of -0.04%. Regarding short-term risk, MDLA is less volatile compared to INTA. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check INTA's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, CLSK has a market cap of 3.3B. Regarding current trading prices, MDLA is priced at $33.99, while CLSK trades at $11.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas CLSK's P/E ratio is -10.65. In terms of profitability, MDLA's ROE is -0.33%, compared to CLSK's ROE of -0.11%. Regarding short-term risk, MDLA is less volatile compared to CLSK. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check CLSK's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, AGYS has a market cap of 3.3B. Regarding current trading prices, MDLA is priced at $33.99, while AGYS trades at $116.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas AGYS's P/E ratio is 238.55. In terms of profitability, MDLA's ROE is -0.33%, compared to AGYS's ROE of +0.05%. Regarding short-term risk, MDLA is less volatile compared to AGYS. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check AGYS's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BRZE has a market cap of 3.2B. Regarding current trading prices, MDLA is priced at $33.99, while BRZE trades at $29.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BRZE's P/E ratio is -28.90. In terms of profitability, MDLA's ROE is -0.33%, compared to BRZE's ROE of -0.22%. Regarding short-term risk, MDLA is less volatile compared to BRZE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BRZE's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, GBTG has a market cap of 3.2B. Regarding current trading prices, MDLA is priced at $33.99, while GBTG trades at $6.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas GBTG's P/E ratio is -67.70. In terms of profitability, MDLA's ROE is -0.33%, compared to GBTG's ROE of -0.04%. Regarding short-term risk, MDLA is less volatile compared to GBTG. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check GBTG's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BLKB has a market cap of 3.2B. Regarding current trading prices, MDLA is priced at $33.99, while BLKB trades at $65.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BLKB's P/E ratio is -11.68. In terms of profitability, MDLA's ROE is -0.33%, compared to BLKB's ROE of -0.89%. Regarding short-term risk, MDLA is less volatile compared to BLKB. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BLKB's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DAVEW has a market cap of 3B. Regarding current trading prices, MDLA is priced at $33.99, while DAVEW trades at $1.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DAVEW's P/E ratio is -7.04. In terms of profitability, MDLA's ROE is -0.33%, compared to DAVEW's ROE of +0.31%. Regarding short-term risk, MDLA is less volatile compared to DAVEW. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DAVEW's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ALIT has a market cap of 3B. Regarding current trading prices, MDLA is priced at $33.99, while ALIT trades at $5.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ALIT's P/E ratio is -96.08. In terms of profitability, MDLA's ROE is -0.33%, compared to ALIT's ROE of -0.01%. Regarding short-term risk, MDLA is less volatile compared to ALIT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ALIT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, BTDR has a market cap of 2.9B. Regarding current trading prices, MDLA is priced at $33.99, while BTDR trades at $14.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas BTDR's P/E ratio is -3.09. In terms of profitability, MDLA's ROE is -0.33%, compared to BTDR's ROE of -0.37%. Regarding short-term risk, MDLA is less volatile compared to BTDR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check BTDR's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, DAVE has a market cap of 2.8B. Regarding current trading prices, MDLA is priced at $33.99, while DAVE trades at $210.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas DAVE's P/E ratio is 59.31. In terms of profitability, MDLA's ROE is -0.33%, compared to DAVE's ROE of +0.31%. Regarding short-term risk, MDLA is less volatile compared to DAVE. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check DAVE's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ALKT has a market cap of 2.8B. Regarding current trading prices, MDLA is priced at $33.99, while ALKT trades at $27.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ALKT's P/E ratio is -73.68. In terms of profitability, MDLA's ROE is -0.33%, compared to ALKT's ROE of -0.11%. Regarding short-term risk, MDLA is less volatile compared to ALKT. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ALKT's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, ALRM has a market cap of 2.8B. Regarding current trading prices, MDLA is priced at $33.99, while ALRM trades at $55.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas ALRM's P/E ratio is 23.48. In terms of profitability, MDLA's ROE is -0.33%, compared to ALRM's ROE of +0.18%. Regarding short-term risk, MDLA is less volatile compared to ALRM. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check ALRM's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, PAR has a market cap of 2.8B. Regarding current trading prices, MDLA is priced at $33.99, while PAR trades at $68.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas PAR's P/E ratio is -26.77. In terms of profitability, MDLA's ROE is -0.33%, compared to PAR's ROE of -0.02%. Regarding short-term risk, MDLA is less volatile compared to PAR. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check PAR's competition here

MDLA plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MDLA stands at 0. In comparison, YOU has a market cap of 2.7B. Regarding current trading prices, MDLA is priced at $33.99, while YOU trades at $29.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MDLA currently has a P/E ratio of N/A, whereas YOU's P/E ratio is 18.33. In terms of profitability, MDLA's ROE is -0.33%, compared to YOU's ROE of +1.18%. Regarding short-term risk, MDLA is less volatile compared to YOU. This indicates potentially lower risk in terms of short-term price fluctuations for MDLA.Check YOU's competition here